Biotech May Outperform in 2018
In this video, Michael goes through three reasons why the biotech sector could outperform in 2018. Michael Kramer and the clients of Mott Capital own shares of ACAD Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does…
- Genres:
- Documentary
- Availability:
- Afghanistan +more